Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°áÇÙ¼º º¹¸·¿°¿¡¼­ CA 125ÀÇ Áø´ÜÀû ÀÇÀÇ Clinical Significance of CA 125 in Patients with Tuberculous Peritonitis

´ëÇѼÒÈ­±âÇÐȸÁö 1998³â 32±Ç 3È£ p.332 ~ 338
¼Ò¼Ó »ó¼¼Á¤º¸
¾ÈÇöÅÃ/Hyun Taek Ahn ¼­°­¼®/±èÇö¼ö/ÃÖ¼º±Ô/À¯Á¾¼±/±è¼¼Á¾/Kang Seok Suh/Hyun Soo Kim/Sung Kyu Choi/Jong Sun Rew/Sei Jong Kim,

Abstract

¿ä¾à
¸ñÀû : CA 125´Â Å»ý±âÀÇ Ã¼°­»óÇǼ¼Æ÷¿¡¼­ Ç¥ÃâµÇ¸ç ´ÜŬ·ÐÇ×üÀÎ OC 125¿¡ ÀÇÇØ ÀÎ
½ÄµÈ´Ù. CA 125 Ç׿øÀÌ ¹ß°ßµÇ´Â ³­°ü, Àڱ󻸷, °æ°ü³»¸· ¹× º¹¸·, È丷, ½É¸·À» ħ¹üÇÏ´Â
¿°ÁõÀ̳ª Á¾¾ç¿¡ ÀÇÇØ CA 125°¡ »ó½ÂÇÏ°Ô µÇ¹Ç·Î ³­¼Ò »óÇÇ¾Ï È¯ÀÚÀÇ Ç÷û¿¡¼­ »Ó ¾Æ´Ï¶ó
°ñ¹Ý¿°, Àڱ󻸷Áõ, °£°æº¯Áõ, ¸¸¼º½ÅºÎÀü ¹× Àڱ󻸷, ³­°ü, °æ°ü³»¸·¾Ï µî¿¡¼­µµ Áõ°¡ÇÏ
´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖÀ¸¸ç ¶ÇÇÑ º¹¸· ħ¹ü°ú º¹¼ö Çü¼ºÀ» ÇÏ´Â °áÇÙ¼º º¹¸·¿°¿¡¼­µµ Áõ°¡µÈ
´Ù°í º¸°íµÇ°í ÀÖ´Ù. ±×·¯³ª °áÇÙ¼º º¹¸·¿°¿¡¼­ CA 125 ÀÇ Áõ°¡¿¡ ´ëÇÑ ÀÓ»óÀû ÀÇÀÇ¿¡ ´ë
Çؼ­´Â ¾ÆÁ÷ È®½ÇÄ¡ ¾Ê´Ù. ÀÌ¿¡ ÀúÀÚµéÀº °áÇÙ¼º º¹¸·¿°¿¡¼­ CA 125ÀÇ Áø´ÜÀû ÀÇÀÇ ¹× º¹
¼öÀÇ °¨º°Áø´Ü¿¡ À¯¿ë¼º ¿©ºÎ¸¦ ¾Ë¾Æº¸±â À§ÇØ º» ¿¬±¸¸¦ ½ÃÇàÇÏ¿´´Ù.
´ë»ó ¹× ¹æ¹ý : 1994³â 1¿ùºÎÅÍ 1998³â 1¿ù±îÁö Àü³²´ëÇб³º´¿ø ³»°ú¿¡ ÀÔ¿øÇÑ È¯ÀÚ Áß
º¹¼ö°Ë»ç¸¦ ½ÃÇàÇÏ¿© ¿øÀÎÁúȯÀ¸·Î¼­ °áÇÙ¼º º¹¸·¿°À¸·Î Áø´ÜµÈ 22¿¹, °£°æº¯Áõ 11¿¹, Ư¹ß
¼º ¼¼±Õ¼º º¹¸·¿° 11¿¹, º¹¸· ¾ÏÁ¾Áõ 12¿¹¿¡ ´ëÇØ Ç÷û CA 125¿Í ¾Æ¿ï·¯ º¹¼öÀÇ CA 125,
ADA¸¦ ÃøÁ¤ ºñ±³ÇÏ¿© ´ÙÀ½°ú °°Àº °á°ú¸¦ ¾ò¾ú´Ù.
°á°ú : 1) °áÇÙ¼º º¹¸·¿°, °£°æº¯Áõ, Ư¹ß¼º ¼¼±Õ¼º º¹¸·¿°, º¹¸· ¾ÏÁ¾Áõ¿¡¼­ CA 125ÀÇ Æò
±ÕÄ¡´Â °¢°¢ 356.5¡¾215.9 U/mL, 326.5¡¾181.7 U/mL, 344.8¡¾437.7 U/mL, 687.2¡¾1277.4
U/mL·Î Àü Áúȯ¿¡¼­ ÀÓ°èÄ¡ÀÎ 35 U/mLÀÌ»óÀ¸·Î Áõ°¡µÇ¾î ÀÖ¾úÀ¸¸ç, °¢ ±º°£¿¡ À¯ÀÇÇÑ Â÷
ÀÌ´Â º¸ÀÌÁö ¾Ê¾Ò´Ù(p>0.05). 2) º¹¼ö¿Í Ç÷ûÀÇ CA 125ºñ(º¹¼ö/Ç÷û CA 125)´Â °áÇÙ¼ºº¹¸·
¿°¿¡¼­ °¡Àå ³ô¾ÒÀ¸³ª Åë°èÇÐÀûÀÎ ÀÇÀÇ´Â ¾ø¾ú´Ù. 3) °áÇÙ¼º º¹¸·¿°¿¡¼­ Ç÷ûÀÇ CA 125¿Í
º¹¼öÀÇ ADA´Â ¼­·Î »ó°ü°ü°è°¡ ÀÖ¾ú´Ù(r=0.5889, p<0.05).
°á·Ð : °áÇÙ¼º º¹¸·¿°¿¡¼­µµ CA 125ÀÇ Áõ°¡°¡ ÀÖÀ¸¹Ç·Î º¹¼ö, º¹Åë, CA 125ÀÇ »ó½ÂÀÌ ÀÖ
´Â ȯÀÚ¿¡¼­ °áÇÙ¼º º¹¸·¿°µµ °í·ÁÇØ¾ß ÇÒ °ÍÀ¸·Î »ç·áµÈ´Ù. ±×·¯³ª °áÇÙ¼º º¹¸·¿°¿¡¼­ Ç÷
û ¹× º¹¼ö¿¡¼­ CA 125ÀÇ Áõ°¡´Â ºñƯÀÌÀû Çö»óÀ¸·Î º¹¼öÀÇ °¨º°Áø´Ü¿¡ À־ ÀÇÀÇ´Â ¾ø
´Â °ÍÀ¸·Î »ç·áµÈ´Ù.
#ÃÊ·Ï#
Background/Aims : The CA 125 is a glycoprotein expressed by coelomic epithelium
during embryonic development. The elevation of CA 125 level was originally found in
patients with epithelial ovarian cancer, and was observed in various benign and
malignant diseases. The aim of this study was to determine the clinical significance of
CA 125 in tuberculous peritonitis.
Methods : The study was performed for 56 subjects with ascites. These subjects
included patients with tuberculous peritonitis (22), liver cirrhosis (11), spontaneous
bacterial peritonitis (11) and peritoneal carcinomatosis (12). CA 125 levels in serum and
ascitic fluid were measured. The correlation between serum CA 125 and ascitic fluid
ADA (adenosine deaminase) was investigated.
Results : In all disease groups, the mean serum values of CA125 were higher than
the cutoff level of 35 U/mL. However, there was no significant difference among groups
(p>0.05). In tuberculous peritonitis, the ratio of CA125 level in ascitic fluid to CA125
level in serum was higher than that in liver cirrhosis and pertoneal carcinomatosis, but
the difference was statistically insignificant. In tuberculous peritonitis, there was a
positive correlation between CA 121 level in serum and ADA level in ascites (r=0.5889,
p<0.01).
Conclusions : It was concluded that possibility of tuberculous peritonitis must be
considered in the diagnosis of patients with ascites and elevated CA 125. However, the
elevated CA 125 is nonspecific finding in the diagnosis of tuberculous peritonitis and
thus, has no special meaning in the differential diagnosis of ascites.

Å°¿öµå

CA125; ADA; °áÇÙ¼º º¹¸·¿°; CA 125; ADA; Tuberculous peritonitis;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

MEDLINE
KCI
KoreaMed
KAMS